112 related articles for article (PubMed ID: 1720884)
1. Coagulation disorders and tumor markers in the diagnosis of pancreatic cancer.
Abbasciano V; Graziano L; Guerra S; Mazzotta D; Pollinzi V; Gilli G; Zavagli G
Oncology; 1991; 48(5):377-82. PubMed ID: 1720884
[TBL] [Abstract][Full Text] [Related]
2. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
Rosove MH; Hocking WG; Harwig SS; Perloff JK
Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
[TBL] [Abstract][Full Text] [Related]
3. Specificity of carcinoembryonic antigen, gastrointestinal cancer-associated antigen, tissue polypeptide antigen, fibrinopeptide A and gamma-glutamyltransferase in the diagnosis and follow-up of gastric cancer.
Abbasciano V; Levato F; Zavagli G
Oncology; 1988; 45(3):159-61. PubMed ID: 2897101
[TBL] [Abstract][Full Text] [Related]
4. Specificity of tumor markers (CEA, GICA, TPA, alpha-FP, FpA, gamma-GT) for the diagnosis of hepatic metastases from large bowel cancers.
Abbasciano V; Levato F; Zavagli G
Med Oncol Tumor Pharmacother; 1989; 6(2):129-32. PubMed ID: 2473362
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease.
Hughes RD; Lane DA; Ireland H; Langley PG; Gimson AE; Williams R
Clin Sci (Lond); 1985 Jun; 68(6):701-7. PubMed ID: 2485273
[TBL] [Abstract][Full Text] [Related]
6. [CEA, GICA, TPA, fibrinopeptide-A, gamma-GT and gastric cancer. A contribution to the rationalization of a combined assay].
Abbasciano V; Graziano L; Arcudi D; Tassinari D; Nielsen I; Sartori S
Recenti Prog Med; 1991 Oct; 82(10):517-9. PubMed ID: 1684676
[TBL] [Abstract][Full Text] [Related]
7. Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease.
Nichols AB; Owen J; Kaplan KL; Sciacca RR; Cannon PJ; Nossel HL
Blood; 1982 Sep; 60(3):650-4. PubMed ID: 6179552
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation.
Kaplan KL; Nossel HL; Drillings M; Lesznik G
Br J Haematol; 1978 May; 39(1):129-46. PubMed ID: 78721
[TBL] [Abstract][Full Text] [Related]
9. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
[TBL] [Abstract][Full Text] [Related]
10. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin].
Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE
Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657
[TBL] [Abstract][Full Text] [Related]
11. Plasmatic markers of haemostatic system activation in patients with solid neoplasms.
Sagripanti A; Carpi A; Ferdeghini M; Baicchi U; Grassi B
J Nucl Med Allied Sci; 1990; 34(4):321-32. PubMed ID: 2151044
[No Abstract] [Full Text] [Related]
12. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM
Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807
[TBL] [Abstract][Full Text] [Related]
13. Amniotic fluid platelet factor 4 and beta-thromboglobulin as markers of structural abnormalities.
Saleh AA; Ozawa T; Isada NB; Johnson MP; Dombrowski MP; Evans MI; Treadwell MB; Mammen EF
Fetal Diagn Ther; 1993; 8(3):175-7. PubMed ID: 7694591
[TBL] [Abstract][Full Text] [Related]
14. Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation.
Walenga JM; Fareed J; Hoppensteadt D
Semin Thromb Hemost; 1984 Oct; 10(4):294-305. PubMed ID: 6240117
[No Abstract] [Full Text] [Related]
15. The application of polyethylene glycol to radioimmunoassays used in haemostasis.
Woodhams BJ; Kernoff PB
Thromb Res; 1983 Feb; 29(3):333-41. PubMed ID: 6189241
[TBL] [Abstract][Full Text] [Related]
16. Fibrinopeptide A, beta-thromboglobulin, and fibrin degradation products as screening test for the diagnosis of deep vein thrombosis.
Wojciechowski J; Olausson M; Korsan-Bengtsen K
Haemostasis; 1983; 13(4):254-61. PubMed ID: 6194049
[TBL] [Abstract][Full Text] [Related]
17. Plasma concentrations of fibrinopeptide A, fibrinogen fragment B beta 1-42 and beta-thromboglobulin following total hip replacement.
Lane DA; Ireland H; Wolff S; Grant R; Jennings S; Allen-Mersh T
Thromb Res; 1982 Apr; 26(2):111-8. PubMed ID: 6180501
[TBL] [Abstract][Full Text] [Related]
18. Platelet activation and fibrinopeptide formation in pulmonary hypertension.
Schulman LL; Grossman BA; Owen J
Chest; 1993 Dec; 104(6):1690-3. PubMed ID: 8252943
[TBL] [Abstract][Full Text] [Related]
19. Increased intravascular coagulation associated with pregnancy.
Gerbasi FR; Bottoms S; Farag A; Mammen E
Obstet Gynecol; 1990 Mar; 75(3 Pt 1):385-9. PubMed ID: 2137574
[TBL] [Abstract][Full Text] [Related]
20. The effect of anticoagulant mixtures on BTG and PF4 levels.
Randi ML; Fabris F; Casonato A; Girolami A
Thromb Haemost; 1981 Aug; 46(2):569. PubMed ID: 6171043
[No Abstract] [Full Text] [Related]
[Next] [New Search]
